CME Group/$CME

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About CME Group

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Ticker

$CME
Primary listing

Industry

Capital Markets

Employees

3,760

ISIN

US12572Q1058

CME Group Metrics

BasicAdvanced
$98B
27.37
$9.94
0.47
$10.50
1.84%

What the Analysts think about CME Group

Analyst ratings (Buy, Hold, Sell) for CME Group stock.

Bulls say / Bears say

CME Group reported a 12% increase in first-quarter profit to $956 million, driven by record trading volumes amid market volatility. (reuters.com)
The company declared a quarterly dividend of $1.25 per share, reflecting confidence in its financial health and commitment to returning value to shareholders. (techdows.com)
Analysts at Keefe, Bruyette & Woods raised their price target for CME Group to $257, indicating a positive outlook on the stock's future performance. (marketbeat.com)
CME's first-quarter profit narrowly missed analysts' estimates, with earnings per share at $2.80 compared to the expected $2.81, due to a 1.1% increase in operating expenses driven by higher technology spending. (reuters.com)
The emergence of FMX Futures as a new competitor poses a potential threat to CME's interest rate futures business, which is a significant revenue driver for the company. (gurufocus.com)
Insider selling activity, including a director selling 10,000 shares and an insider selling 11,592 shares, may raise concerns about the company's future prospects among investors. (techdows.com)
Data summarised monthly by Lightyear AI. Last updated on 22 May 2025.

CME Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CME Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CME

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jun25
CME Group
Dividend·Payment
$1.25Per share
FAQs